{"id":519537,"date":"2022-10-27T13:05:00","date_gmt":"2022-10-27T10:05:00","guid":{"rendered":"https:\/\/ipn.md\/new-compensated-pharmaceutical-to-become-available-next-week\/"},"modified":"2026-07-18T23:22:57","modified_gmt":"2026-07-18T20:22:57","slug":"new-compensated-pharmaceutical-to-become-available-next-week","status":"publish","type":"post","link":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/","title":{"rendered":"New compensated pharmaceutical to become available next week"},"content":{"rendered":"<p>The preparation with the common international name <span style=\"background:white\">Dapagliflozin that was recently put on the list of compensated drugs should become available from next week, the director general of the National Health Insurance Company (CNAM) <\/span>Ion Dodon told a news conference. The drug is indicated to persons with type 2 diabetes and with heart failure, <span style=\"background:white\">IPN reports.<\/p>\n<p>According to the official, the Company is to negotiate optimal prices with representatives of Moldovan drug distributors and producers and to add new medicines to the list of compensated drugs. It is also planned to digitize the services, to exclude the human factor where persons need to make an appointment for high performance services. All these measures form part of the information campaign \u201cIt\u2019s better to be insured\u201d that was launched today and will last until the end of next March<\/span>.<\/p>\n<p>\u201cWe lay emphasis on the fact that the insured persons who pay the mandatory health insurance premium receive medical services and have access to compensated drugs and devices not as a favor but as something granted,\u201d said the CNAM director.<\/p>\n<p>Ion Dodon said that if the persons receive costly medical assistance amounting to tens or hundreds of thousands of lei, they can be informed at home about the estimated value of the provided medical services so that they know they received medical services paid by the CNAM as medically insured persons.<\/p>\n<p>In Moldova there are three categories of insured persons, namely: employed persons or persons who get other recompenses (about one third of Moldova\u2019s population), persons insured by the Government, such as pensioners, persons with disabilities, unemployed persons, children and students, and persons who need to buy insurance individually as they have income but do not form part of salary earners.<\/p>\n<div id=\"related_pages_keyphrase\" style=\"display:none;\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The preparation with the common international name Dapagliflozin that was recently put on the list of compensated drugs should become available from next week, the director general of the National&hellip;<\/p>\n","protected":false},"author":0,"featured_media":519319,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[138],"tags":[],"class_list":["post-519537","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-society"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New compensated pharmaceutical to become available next week - ipn.md<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New compensated pharmaceutical to become available next week - ipn.md\" \/>\n<meta property=\"og:description\" content=\"The preparation with the common international name Dapagliflozin that was recently put on the list of compensated drugs should become available from next week, the director general of the National&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/\" \/>\n<meta property=\"og:site_name\" content=\"ipn.md\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ipn.md\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-27T10:05:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-18T20:22:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ipn.md\/wp-content\/uploads\/2022\/10\/1093018__635a57f4c39fa-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipn_moldova\" \/>\n<meta name=\"twitter:site\" content=\"@ipn_moldova\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"New compensated pharmaceutical to become available next week\",\"datePublished\":\"2022-10-27T10:05:00+00:00\",\"dateModified\":\"2026-07-18T20:22:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/\"},\"wordCount\":297,\"publisher\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/ru\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ipn.md\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1093018__635a57f4c39fa-1.jpg\",\"articleSection\":[\"Society\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/\",\"url\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/\",\"name\":\"New compensated pharmaceutical to become available next week - ipn.md\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/ru\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ipn.md\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1093018__635a57f4c39fa-1.jpg\",\"datePublished\":\"2022-10-27T10:05:00+00:00\",\"dateModified\":\"2026-07-18T20:22:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ipn.md\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1093018__635a57f4c39fa-1.jpg\",\"contentUrl\":\"https:\\\/\\\/ipn.md\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/1093018__635a57f4c39fa-1.jpg\",\"width\":750,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ipn.md\\\/en\\\/new-compensated-pharmaceutical-to-become-available-next-week\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ipn.md\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New compensated pharmaceutical to become available next week\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ipn.md\\\/ru\\\/#website\",\"url\":\"https:\\\/\\\/ipn.md\\\/ru\\\/\",\"name\":\"ipn.md\",\"description\":\"Agen\u0163ie de pres\u0103 independent\u0103\",\"publisher\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/ru\\\/#organization\"},\"alternateName\":\"IPN\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ipn.md\\\/ru\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ipn.md\\\/ru\\\/#organization\",\"name\":\"IPN - Agen\u0163ia de pres\u0103 independent\u0103\",\"url\":\"https:\\\/\\\/ipn.md\\\/ru\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ipn.md\\\/ru\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ipn.md\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/photo_2025-02-05_10-45-59.jpg\",\"contentUrl\":\"https:\\\/\\\/ipn.md\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/photo_2025-02-05_10-45-59.jpg\",\"width\":750,\"height\":500,\"caption\":\"IPN - Agen\u0163ia de pres\u0103 independent\u0103\"},\"image\":{\"@id\":\"https:\\\/\\\/ipn.md\\\/ru\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ipn.md\",\"https:\\\/\\\/x.com\\\/ipn_moldova\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New compensated pharmaceutical to become available next week - ipn.md","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/","og_locale":"en_US","og_type":"article","og_title":"New compensated pharmaceutical to become available next week - ipn.md","og_description":"The preparation with the common international name Dapagliflozin that was recently put on the list of compensated drugs should become available from next week, the director general of the National&hellip;","og_url":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/","og_site_name":"ipn.md","article_publisher":"https:\/\/www.facebook.com\/ipn.md","article_published_time":"2022-10-27T10:05:00+00:00","article_modified_time":"2026-07-18T20:22:57+00:00","og_image":[{"width":750,"height":500,"url":"https:\/\/ipn.md\/wp-content\/uploads\/2022\/10\/1093018__635a57f4c39fa-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@ipn_moldova","twitter_site":"@ipn_moldova","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/#article","isPartOf":{"@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/"},"author":{"name":"","@id":""},"headline":"New compensated pharmaceutical to become available next week","datePublished":"2022-10-27T10:05:00+00:00","dateModified":"2026-07-18T20:22:57+00:00","mainEntityOfPage":{"@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/"},"wordCount":297,"publisher":{"@id":"https:\/\/ipn.md\/ru\/#organization"},"image":{"@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/#primaryimage"},"thumbnailUrl":"https:\/\/ipn.md\/wp-content\/uploads\/2022\/10\/1093018__635a57f4c39fa-1.jpg","articleSection":["Society"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/","url":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/","name":"New compensated pharmaceutical to become available next week - ipn.md","isPartOf":{"@id":"https:\/\/ipn.md\/ru\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/#primaryimage"},"image":{"@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/#primaryimage"},"thumbnailUrl":"https:\/\/ipn.md\/wp-content\/uploads\/2022\/10\/1093018__635a57f4c39fa-1.jpg","datePublished":"2022-10-27T10:05:00+00:00","dateModified":"2026-07-18T20:22:57+00:00","breadcrumb":{"@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/#primaryimage","url":"https:\/\/ipn.md\/wp-content\/uploads\/2022\/10\/1093018__635a57f4c39fa-1.jpg","contentUrl":"https:\/\/ipn.md\/wp-content\/uploads\/2022\/10\/1093018__635a57f4c39fa-1.jpg","width":750,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/ipn.md\/en\/new-compensated-pharmaceutical-to-become-available-next-week\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipn.md\/"},{"@type":"ListItem","position":2,"name":"New compensated pharmaceutical to become available next week"}]},{"@type":"WebSite","@id":"https:\/\/ipn.md\/ru\/#website","url":"https:\/\/ipn.md\/ru\/","name":"ipn.md","description":"Agen\u0163ie de pres\u0103 independent\u0103","publisher":{"@id":"https:\/\/ipn.md\/ru\/#organization"},"alternateName":"IPN","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipn.md\/ru\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ipn.md\/ru\/#organization","name":"IPN - Agen\u0163ia de pres\u0103 independent\u0103","url":"https:\/\/ipn.md\/ru\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipn.md\/ru\/#\/schema\/logo\/image\/","url":"https:\/\/ipn.md\/wp-content\/uploads\/2024\/11\/photo_2025-02-05_10-45-59.jpg","contentUrl":"https:\/\/ipn.md\/wp-content\/uploads\/2024\/11\/photo_2025-02-05_10-45-59.jpg","width":750,"height":500,"caption":"IPN - Agen\u0163ia de pres\u0103 independent\u0103"},"image":{"@id":"https:\/\/ipn.md\/ru\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ipn.md","https:\/\/x.com\/ipn_moldova"]}]}},"_links":{"self":[{"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/posts\/519537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/comments?post=519537"}],"version-history":[{"count":1,"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/posts\/519537\/revisions"}],"predecessor-version":[{"id":520752,"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/posts\/519537\/revisions\/520752"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/media\/519319"}],"wp:attachment":[{"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/media?parent=519537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/categories?post=519537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipn.md\/en\/wp-json\/wp\/v2\/tags?post=519537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}